Literature DB >> 8871765

Both TH1 and TH2 cytokine mRNAs are expressed in the NOD mouse pancreas in vivo.

B E Faulkner-Jones1, M Dempsey-Collier, T E Mandel, L C Harrison.   

Abstract

In NOD mice, autoimmune recognition and destruction of pancreatic islet beta-cells appear to be independently regulated: all mice develop cellular infiltration of the islets (insulitis), but not all develop diabetes. The destructive potential of the insulitis lesion may depend on the balance between the two CD4+ T-cell subsets. TH1 and TH2, that mediate cellular-cytotoxic and humoral responses, respectively. With a semi-quantitative reverse transcriptase-PCR assay, we examined whether the disease process was reflected in the profiles of TH1 (IL-2, IFN-gamma and IL-12) and TH2 (IL-4, IL-6 and IL-10) cytokine mRNAs expressed in pancreata of NOD mice. Pancreata rather than isolated islets were examined to minimize manipulation ex vivo to preserve the expression of cytokine transcripts in vivo. At age 6 weeks, when 70% of mice had insulitis, all cytokine transcripts were detected in most pancreata, and their expression levels corresponded to the degree of insulitis. Similarly, during induction of diabetes with cyclophosphamide all transcripts were detected and levels corresponded with the degree of insulitis. In one-year-old mice without diabetes, all transcripts were detected but levels did not correspond to the degree of insulitis. Thus, in pancreata of NOD mice with different degrees of insulitis, we were unable to demonstrate, at the RNA level, polarisation of cytokine expression into either a TH1 or TH2 profile. This finding does not, however, exclude expression of distinct cytokine transcripts by immuno-inflammatory cells within the islet lesion, which might be revealed by in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871765     DOI: 10.3109/08916939608995333

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

1.  Identification of a novel type 1 diabetes susceptibility gene, T-bet.

Authors:  Yuka Sasaki; Kenji Ihara; Nobuo Matsuura; Hitoshi Kohno; Seiho Nagafuchi; Ryuichi Kuromaru; Koichi Kusuhara; Ryu Takeya; Timothy Hoey; Hideki Sumimoto; Toshiro Hara
Journal:  Hum Genet       Date:  2004-07-06       Impact factor: 4.132

Review 2.  FLT3 inhibitors for the treatment of autoimmune disease.

Authors:  Katharine A Whartenby; Donald Small; Peter A Calabresi
Journal:  Expert Opin Investig Drugs       Date:  2008-11       Impact factor: 6.206

3.  1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes.

Authors:  K Casteels; M Waer; R Bouillon; J Depovere; D Valckx; J Laureys; C Mathieu
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 4.  Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function.

Authors:  Richard E Kast
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.